Quick Answer
ProPhase Labs, Inc. reported Diluted EPS of $2.61 per share (loss) for fiscal year 2024.
ProPhase Labs, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2024 | -$2.61 | -166.3% |
| 2023 | -$0.98 | -196.1% |
| 2022 | $1.02 | +155.0% |
| 2021 | $0.40 | +322.2% |
| 2020 | -$0.18 | -20.0% |
| 2018 | -$0.15 | -105.8% |
| 2017 | $2.59 | +1623.5% |
| 2016 | -$0.17 | +22.7% |
| 2015 | -$0.22 | +53.2% |
| 2014 | -$0.47 | -1666.7% |
| 2013 | $0.03 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.16 | +54.3% | -45.5% |
| June 30, 2025 | -$0.11 | +66.7% | -200.0% |
| March 31, 2025 | $0.11 | +130.6% | +131.4% |
| September 30, 2024 | -$0.35 | -16.7% | -6.1% |
| June 30, 2024 | -$0.33 | -65.0% | +8.3% |
| March 31, 2024 | -$0.36 | -1300.0% | -20.0% |
| September 30, 2023 | -$0.30 | -600.0% | -50.0% |
| June 30, 2023 | -$0.20 | -150.0% | -766.7% |
- ProPhase Labs, Inc. showed a decrease of -166.3% in Diluted EPS compared to the prior fiscal year.
- Over the 2013–2024 period, ProPhase Labs, Inc.’s diluted eps has declined by 8800.0% (from $0.03 per share to $2.61 per share (loss)).
- The most recent figure is from ProPhase Labs, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 1, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: